Radical multimodality therapy for malignant pleural mesothelioma.

CONCLUSIONS: The overall strength of the evidence gathered in this review is low and there is a lack of available evidence to support the use of radical multimodality therapy in routine clinical practice (particularly as one trial suggests greater harm). Given the added cost of multimodality treatment and the possible increase in risk of adverse effects, the lack of evidence of their effectiveness probably means that these interventions should currently be limited to clinical trials alone. PMID: 29309720 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29309720?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - January 8, 2018 Category: General Medicine Authors: Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M Tags: Cochrane Database Syst Rev Source Type: research